Publications by authors named "Erica Baima"
Article Synopsis
- De-escalation strategies, particularly dose spacing (DS), are being explored for treating atopic dermatitis (AD) patients on dupilumab, allowing longer intervals between injections for those stable or experiencing side effects.
- A retrospective cohort study assessed the safety and effectiveness of DS in AD patients aged ≥18, comparing outcomes before and after DS with a control group not undergoing DS.
- Results showed that after implementing DS, the patients maintained stable skin condition and quality of life measures without significant differences when compared to the control group, indicating DS is both effective and safe for managing severe AD.
